Abstract 5237: Engineered probiotics direct the antigen specificity of CAR-T cells <i>in situ</i>
Rosa L. Vincent(Columbia University), Tal Danino(Herbert Irving Comprehensive Cancer Center), Fangda Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Candice R. Gurbatri(Tempus Labs (United States)), Nicholas Arpaia(Columbia University Irving Medical Center), Ana Vardoshvili(Columbia University)
Cited by 3
Related Papers
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
|Science|2017|1.8k
Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease
|Biology of Blood and Marrow Transplantation|2015|762
Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies
|Science Translational Medicine|2020|600
Engineering bacteria as interactive cancer therapies
|Science|2022|411
Probiotic-guided CAR-T cells for solid tumor targeting
|Science|2023|251